As you may have seen in our BioLargo Spotlight on Tuesday, BioLargo President and CEO Dennis Calvert delivered a presentation on BioLargo's commercial successes and exciting technology platforms at the 2018 Planet MicroCap investor conference. This is one of several conferences Dennis will attend in the next few months as the company continues to seek strategic partners and investors to accelerate the company's revenue growth and the commercialization of its high growth potential technologies such as the disruptive Advanced Oxidation System (AOS).
You can see Dennis' full slide show from the Planet MicroCap conference here:
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
Friday, 27 April 2018
Tuesday, 24 April 2018
BioLargo Spotlight: BioLargo on the Road
We have a busy month coming up for BioLargo’s business
development team! While our scientists are hard at work preparing our platform
technology for commercialization and our engineers are busy serving clients,
our business development folks are forging new relationships and presenting our
company’s technology and story to important audiences intrigued by our story of
technology innovation.
This week, President and CEO Dennis Calvert will be
presenting BioLargo’s story to an investor audience at the annual Planet
MicroCap Showcase 2018. The presentation will be closed to the public, but the
audience will be comprised of investors and interested stakeholders in
disruptive new technology companies. A press release about this presentation
can be read here.
BioLargo’s Director of Business Development Dr. Shan Yong
and BioLargo Water scientist Jenny Boutros will be presenting a special seminar
about our company’s technologies at CSU Fresno on April 25th. The
seminar, titled “Innovation, Collaboration and Commercialization for Air and
Water Solutions for Agriculture and F&B Industries” will be delivered to
agriculture and food & beverage industry stakeholders and esteemed academics.
Finally, BioLargo’s Dennis Calvert and Odor-No-More’s
President Joe Provenzano will be presenting at the 2018 Waste Expo hosted
by Waste360 in Las Vegas, NV. Dennis and Joe will be taking BioLargo’s
disruptive industrial odor control product CupriDyne Clean on the road and
meeting with countless prospective users of the product.
What is a BioLargo
Spotlight?
It’s an exciting time
at BioLargo. We’re moving fast, and it can be difficult to keep our
stockholders and the investing public informed of our progress. In light of
this, we will be posting a series of short articles titled “BioLargo
Spotlight”, highlighting certain business activities and other important
information in between our required SEC filings. Of course, these do not
replace our public filings, which contain more complete information than can be
delivered in this forum, and thus we urge you to carefully read and rely on
those filings for definitive information, and to review our risk factors and
caution regarding forward-looking statements. We are optimistic about our
business as we work hard to continue to grow and ultimately generate profits
for our stockholders.
Friday, 20 April 2018
BioLargo CEO Dennis Calvert Delivers Interview on BioLargo's Upcoming AOS Commercial Pilot on Uptick's Stock Day Podcast
Yesterday, BioLargo President and CEO Dennis Calvert gave an in-depth interview about the company's recent important news of being awarded CAD$235,000 from NRC-IRAP to fund an upcoming commercial pilot in the poultry processing industry. The interview was on Uptick Newswire's popular "Stock Day" podcast hosted by Everett Jolly.
Dennis digs deep in this interview and delivers information about the upcoming commercial pilot, including: the pilot's rationale, the implications of the NRC-IRAP funding, and what the pilot means for the commercial future of the AOS.
Listen to the interview at Uptick Newswire's website here, or click the button below to listen on our blog!
Dennis digs deep in this interview and delivers information about the upcoming commercial pilot, including: the pilot's rationale, the implications of the NRC-IRAP funding, and what the pilot means for the commercial future of the AOS.
Listen to the interview at Uptick Newswire's website here, or click the button below to listen on our blog!
Wednesday, 18 April 2018
BioLargo Spotlight: BioLargo Water receives funding from the Government of Canada for AOS Pilot Project
Today we’re happy to
announce that BioLargo Water Canada has been awarded $235,000 CAD from the
Canadian Government’s Industrial Research Assistance Program (NRC-IRAP) to fund
our first on-site pilot project.
You can read our official press release about this pivotal
milestone here.
As many of you know, BioLargo’s Advanced Oxidation System
(AOS) has, through the past few
years of development, been transformed from a
tiny beaker-sized proof-of-concept device to a full-fledged pre-commercial
“Alpha” prototype. Building a prototype like this is a crucial step in taking
an innovative product to market, but it’s not sufficient alone.
Another big part of the equation is the need for commercial pilots,
where the product is tested in a real field environment against real-world
industrial challenges. Naturally, we have been working hard to establish these
commercial pilot projects for our AOS.
Now, we’re pleased to say we have been awarded significant
financial support from NRC-IRAP to fund our first commercial pilot, and have
secured an industrial poultry processing client partner on whose site our pilot
AOS will be installed. This commercial pilot, which is planned to take place
throughout 2018 and early 2019, will see the AOS installed on-site at a
Canadian poultry producer’s processing facility, where its ability to reliably
and cost-effectively treat poultry wastewater will be demonstrated
exhaustively.
This is an important step for our AOS technology, as well as
for our company. We are confident in our disruptive water treatment technology
and have proven its treatment capabilities in the lab ad nauseum. However, a pilot project for the AOS, as with any
technology, is crucial to prove its reliability to industry stakeholders as
well the capital cost and operating costs of our technology at-scale. These data
will be critical to pave the way for
future market adoption. And, as you might imagine, we have many other pilots in
evaluation.
Subscribe to:
Posts (Atom)